Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03696758 · ClinicalTrials.gov registry record · Phase 2
Improving Right Ventricular Function in Young Adults Born Preterm
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT03696758: Completed Phase 2 study, sponsored by University of Wisconsin, Madison.
NCT03696758 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03696758, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the short-term effects of sildenafil and metoprolol on heart function in young adults born premature.
Primary Outcome
To characterize energy efficiency, the total Kinetic Energy across the cardiac cycle is normalized to right ventricular end-diastolic volume and left ventricular end-diastolic volume, respectively. Analysis will be completed in blinded fashion. Two imaging scans will be done - one pre and one post Metoprolol intervention. Total time from Pre-intervention scan till post intervention scan may take up to 2 hours.
Interventions
- PROCEDURE Electrocardiogram
- PROCEDURE Cardiac Magnetic Resonance Imaging
- DRUG Sildenafil
- DRUG Metoprolol
- PROCEDURE Pulmonary Function Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2020-02-24 |
| Phase | Phase 2 |
What the finished NCT03696758 record still lists
NCT03696758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which Electrocardiogram is the first listed.
NCT03696758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03696758 about?
NCT03696758 is a clinical study titled "Improving Right Ventricular Function in Young Adults Born Preterm". The purpose of this research is to evaluate the short-term effects of sildenafil and metoprolol on heart function in young adults born premature.
What is the current status of trial NCT03696758?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2018-10-30. Estimated completion is 2020-02-24.
What interventions are being tested in trial NCT03696758?
The interventions under investigation include: Electrocardiogram (PROCEDURE), Cardiac Magnetic Resonance Imaging (PROCEDURE), Sildenafil (DRUG), Metoprolol (DRUG), Pulmonary Function Testing (PROCEDURE).
Who is sponsoring clinical trial NCT03696758?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03696758's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI